Jessica Perl's Insider Trades & SAST Disclosures

Jessica Perl's most recent trade in Emergent Biosolutions Inc was a trade of 104,282 Common Stock done . Disclosure was reported to the exchange on April 29, 2026.

Share

Note

This is a custom search result for pattern Jessica Perl.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Emergent Biosolutions Inc	Jessica Perl	SVP, General Counsel, Corp Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Apr 2026	104,282	165,286 (0%)	0%		0	Common Stock
Emergent Biosolutions Inc	Jessica Perl	SVP, General Counsel, Corp Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2026	46,702	142,647	-		-	Employee Stock Option (Right to buy)
Emergent Biosolutions Inc	Jessica Perl	SVP, General Counsel, Corp Sec	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.44 per share.	03 Mar 2026	6,465	61,004 (0%)	0%	8.4	54,565	Common Stock
Emergent Biosolutions Inc	Jessica Perl	SVP, General Counsel, Corp Sec	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.03 per share.	09 Feb 2026	918	67,469 (0%)	0%	11.0	10,126	Common Stock
Emergent Biosolutions Inc	Jessica Perl	SVP, General Counsel, Corp Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2025	62,500	68,387 (0%)	0%		0	Common Stock
Emergent Biosolutions Inc	Jessica Perl	SVP, General Counsel, Corp Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2025	62,500	95,945	-		-	Employee Stock Options (Right to Buy)
Emergent Biosolutions Inc	Jessica Perl	SVP, General Counsel, Corp Sec	Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.00 per share.	09 Feb 2025	918	5,887 (0%)	0%	10	9,180	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades